Our founders created MediMabs as a response to their desire to be involved in the development of the improvements needed in the market as well as to capture this new niche.
MédiMabs is application driven. We analyze the way antibodies are being used for modern research. Our state-of-the-art R&D facility allows us to develop research tools to help expedite positive results to scientific experiments.
As a distributor we search for novel and known antibodies that are in high demand with increasing selection and for which adequate references and high quality application specifications are available. MédiMabs focuses on antibodies with the greatest flexibility of use, i.e., multifunctional and cross-reactivity attributes/profiles highly suited and tailored for research applications. MédiMabs intends to focus, in the beginning stage, on areas more familiar to the founders which include cancer, cell biology, inflammation and neuroscience.
Working closely with the technology transfer office of respective research institutions, MédiMabs negotiates unique blanket and individual licenses with timed exclusivity. Our agreements are based on royalty payments only. They are kept standard and simplified in order to expedite the process. Through flexible and innovative arrangements made with the source providers, we ensure a level of support and consultation related services to the customer unparalleled in the industry.
We have created an in-house state of the art antibody facility that allows us to carry out all scale-up preparations of licensed antibodies as well the de-novo generation of new antibodies. Being the manufacturer of the Mabs we sell confers to MédiMabs full quality control and ensures timely distribution which allows for the development and production of highly detailed agent specification sheets and detailed notes.
We are very concious of the resources and fund limitations of researchers. MédiMabs endeavours to provide the best service at the lowest prices.
MédiMabs is committed to customer satisfaction. We believe in dynamic and easy dialogue which applies state-of-the-art technology at every level. Our web portal not only allows researchers to efficiently obtain their needed antibodies, but it contains detailed information on all of our products. It also includes a knowledge base (assembled with the full input from our source providers), which allows for quick access to information when questions arise. Our staff is continuously updated on the latest trends in biomedical research. Being on the cutting edge of research and technology allows us to offer our customers the most efficient support in the industry. Maintaining a close relationship with our suppliers allows us to address problems and offer satisfactory solutions in a timely manner.
Our expertise lies in our founders. All our founding members possess vast experience and numerous connections in the biomedical research community, particularly in the fields of cancer, cell biology, inflammation and neuroscience. They have direct access to newly-generated antibodies in research laboratories worldwide and their involvement in the pharmaceutical and biotechnology sphere further broadens the access to a larger variety of Mabs . Their hands-on use of antibodies in their own research activities allows MédiMabs to respond to the antibody needs in most medical research fields.
We invite you to browse our catalogue and knowledge base; fill out a licensing or de novo request so that we may contact you about the commercialization of your monoclonal antibodies. Order your projects antibodies through our secure e-commerce section. Request information on the de-novo generation of antibodies you need. MédiMabs does it all. Feel free to contact us at
, or by telephone (514) 940-MABS or toll free 1-888-940-MABS.
